SUPPLEMENTAL TRIPTORELIN FOR THE TREATMENT OF OCD IN PATIENTS UNDERGOING SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)

Volume 21 No 2 (2023)

Muhammad Hussain, Dr Moeza Razaq, Dr Mustanser Masood, Atipan Saimmai, Dr Iqra Hassan

DOI: 10.48047/NQ.2023.21.2.NQ23006

Abstract

Analog triptorelin is one of the most effective injectable treatments for reproductive problems, particularly metastatic castration-resistant prostate. Based on the results of previous studies, we predicted that long-term therapy with a gonadotropin-releasing hormone (GnRH) ananalognamely triptorelin, may effectively cure obsessive-compulsive disorder (OCD). The aim of this study was to evaluate injectable testosterone injection's effectiveness in OCD patients.

Keywords

Triptorelin, Treatment, OCD

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.